AMD is the leading cause of blindness in the Western world. Around 200 million suffer from it, and that number is expected to grow to nearly 300 million by 2040.

That means that 1 in 8 Westerners over the age of 60 can expect to develop age-related macular degeneration.

It’s a worrying statistic because not everyone responds to current treatments and half of the patients only have a partial response.

It’s early days yet, but a breakthrough treatment developed initially with cancer in mind, could potentially stop the formation of excess blood vessels in the eye, preventing the worst effects of wet AMD.

It’s still only in animal trials, but doctors see a great deal of potential in the years ahead.

Find out more in our story below.